Expanded, universal donor natural killer cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Expanded, universal donor natural killer cells, covering 2024-11-04 to 2024-11-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AML [Phase 1, Phase 2]